-
Bruckner L, Kihm U. Alternatives for potency testing of veterinary vaccines: rabies vaccine as a model[J]. Dev Biol Stand, 1986, 64(): 93-97.
-
Barth R, Diderrich G, Weinmann E. NIH test, a problematic method for testing potency of inactivated rabies vaccine[J]. Vaccine, 1988, 6(4): 369-377. doi: 10.1016/0264-410X(88)90185-5
-
Cliquet F, Aubert M, Sagne L. Development of a fluorescent antibody virus neutralization test (FAVN test) for the quantitation of rabies-neutralizing antibody[J]. J Immunol Mthods, 1998, 212(1): 79-87. doi: 10.1016/S0022-1759(97)00212-3
-
Ferguson M, Heath A. Report of a collaborative study to assess the determination of glycoprotein antigen content of rabies vaccines for human use[J]. Biologicals, 1992, 20(): 143-154. doi: 10.1016/S1045-1056(05)80062-4
-
Ferguson M, Schild G C. A single-radial-immunodiffusion technique for the assay of rabies glycoprotein antigen: application to potency tests of vaccines against rabies[J]. J Gen Virol, 1982, 59(1): 197-201. doi: 10.1099/0022-1317-59-1-197
-
Fernández I, Pe a A, Teso N D. Clinical Biochemistry Parameters in C57BL/6J Mice after Blood Collection from the Submandibular Vein and Retroorbital Plexus[J]. J Am Assoc Lab Anim Sci, 2010, 49(2): 202-206.
-
Fitzgerald E A, Gallagher M, Hunter W S. Use of the antibody assay in immunized mice for the determination of rabies vaccine potency[J]. Dev Biol Stand, 1978, 40(): 183-186.
-
Fournier-Caruana J, Poirier B, Haond G. Inactivated rabies vaccine control and release: use of an ELISA method[J]. Biologicals, 2003, 31(1): 9-16. doi: 10.1016/S1045-1056(02)00070-2
-
Gamoh K, Senda M, Itoh O. Use of ELISA for in vitro potency test of rabies vaccines for animal use[J]. Biologicals, 1996, 24(2): 95-101. doi: 10.1006/biol.1996.0012
-
Gaddis G M, Gaddis M L. Introduction to biostaticstics: Part 2, Descriptive statistics[J]. Ann Emerg Med, 1990, 19(3): 309-315. doi: 10.1016/S0196-0644(05)82052-9
-
Gamoh K, Shimazaki Y, Senda M. Establishment of a potency test by ELISA for a rabies vaccine for animal use in Japan[J]. J Vet Med Sci, 2003, 65(6): 685-688. doi: 10.1292/jvms.65.685
-
Habel K. 1996 Laboratory techniques in rabies: Habel test for potency[J]. Monogr Ser World Health Organ, 1996, (23): 369-373.
-
Hu R L, Fooks A R, Zhang S F. Inferior rabies vaccine quality and low immunization coverage in dogs (Canis familiaris) in China[J]. Epidemiol Infect, 2008, 136(11): 1556-1563. doi: 10.1017/S0950268807000131
-
Kr mer B, Bruckner L, Daas A. Collaborative study for validation of a serological potency assay for rabies vaccine (inactivated) for veterinary use[J]. Pharmeur Bio Sci Notes, 2010, 2010(2): 37-55.
-
Kr mer B, Schildger H, Behrensdorf-Nicol H A. The rapid fluorescent focus inhibition test is a suitable method for batch potency testing of inactivated rabies vaccines[J]. Biologicals, 2009, 37(2): 119-126. doi: 10.1016/j.biologicals.2009.01.001
-
Lafon M, Perrin P, Versmisse P. Use of a monoclonal antibody for quantification of rabies vaccine glycoprotein by enzyme immunoassay[J]. J Biol Stand, 1985, 13(): 295-301. doi: 10.1016/S0092-1157(85)80042-1
-
Lindbladh C, Mosbach K, Bülow L. Use of genetically prepared enzyme conjugates in enzyme immunoassay[J]. Trends Biochem Sci, 1993, 18(8): 279-283. doi: 10.1016/0968-0004(93)90034-K
-
Monograph European Pharmacopoeia. 1985. Vaccinum rabiei inactivatum ad usum veterinarium. In: Monograph European Pharmacopoeia, 2nd Ed. pp451.
-
Mousli M, Turki I, Kharmachi H. Recombinant single-chain Fv antibody fragment-alkaline phosphatase conjugate: a novel in vitro tool to estimate rabies viral glycoprotein antigen in vaccine manufacture[J]. J Virol Methods, 2007, 146(1-2): 246-256. doi: 10.1016/j.jviromet.2007.07.015
-
Nagarajan T, Reddy G S, Mohana Subramanian B. A simple immuno-capture ELISA to estimate rabies viral gly colprotein antigen in vaccine manufacture[J]. Biologicals, 2006, 34(1): 21-27. doi: 10.1016/j.biologicals.2005.07.004
-
Nimmagadda S V, Aavula S M, Biradhar N. Recombinant diabody-based immunocapture enzyme-linked immunosorbent assay for quantification of rabies virus glycoprotein[J]. Clin Vaccine Immunol, 2010, 17(8): 1261-1268. doi: 10.1128/CVI.00204-10
-
Perrin P, Morgeaux S, Sureau P. In vitro rabies vaccine potency appraisal by ELISA: advantages of the immunocapture method with a neutralizing anti-glycoprotein monoclonal antibody[J]. Biologicals, 1990, 18(): 321-330. doi: 10.1016/1045-1056(90)90037-Z
-
Rooijakkers E, Groen J, Uittenbogaard J. Development and evaluation of alternative testing methods for the in vivo NIH potency test used for the quality control of inactivated rabies vaccines[J]. Dev Biol Stand, 1996, 86(): 137-145.
-
Seligmann EB Jr. Laboratory techniques in rabies. Potency-test requirements of the United State National Institutes of Health (NIH)[J]. Monogr Ser World Health Organ, 1996, (23): 360-368.
-
World Health Organization. 2005. WHO Expert Consultation on Rabies. In: First Report WHO Technical Report Series No. 931. Geneva: World Health Organization. pp31-56.
-
Wu X F, Hu R L, Zhang Y Z. Reemerging rabies and lack of systemic surveillance in People's Republic of China[J]. Emerg Infect Dis, 2009, 15(8): 1159-1164. doi: 10.3201/eid1508.081426
-
Wunderli P S, Dreesen D W, Miller T J. The rabies peripheral challenge test: more accurate determination of vaccine potency[J]. Vaccine, 2006, 24(): 7115-7123. doi: 10.1016/j.vaccine.2006.06.078
-
Wunderli P S, Dreesen D W, Miller T J. Effects of vaccine route and dosage on protection from rabies after intracerebral challenge in mice[J]. Am J Vet Res, 2003, 64(4): 491-498. doi: 10.2460/ajvr.2003.64.issue-4
-
Wunderli P S, Shaddock J H, Schmid D S. The protective role of humoral neutralizing antibody in the NIH potency test for rabies vaccines[J]. Vaccine, 1991, 9(): 638-642. doi: 10.1016/0264-410X(91)90188-C